The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Apr. 14, 2015
Applicant:

Advaxis, Inc., Princeton, NJ (US);

Inventors:

Anu Wallecha, Yardley, PA (US);

Robert Petit, Newtown, PA (US);

Assignee:

ADVAXIS, INC., Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/12 (2006.01); C07K 14/195 (2006.01); C12N 1/36 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/195 (2013.01); C12N 1/36 (2013.01); C12N 7/00 (2013.01); A61K 2039/522 (2013.01); A61K 2039/523 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); C07K 2319/55 (2013.01); C12N 2710/20034 (2013.01); C12N 2710/20051 (2013.01);
Abstract

The present invention provides methods of treating, protecting against and inducing an immune response against a tumor or cancer, comprising the step of administering to a subject a recombinantstrain. In one embodiment the present invention relates to a recombinantstrain, said recombinantstrain comprising a recombinant nucleic add, said nucleic add comprising a first open reading frame encoding a recombinant polypeptide comprising a first N-terminal fragment of an LLO protein fused to a heterologous antigen or fragment thereof, and wherein said recombinant nucleic add further comprises a second open reading frame encoding a mutant PrfA protein.


Find Patent Forward Citations

Loading…